LD-2 disclosure · 2nd Quarter - Report
ALLERGAN INC (FORMERLY ACTAVIS INC )
Client
- Name
- ALLERGAN INC (FORMERLY ACTAVIS INC )
- Description
- Pharmaceutical manufacturer specializing in generic, brand and biosimilar products.
- Location
- District of Columbia · United States of America
Registrant
- Description
- Government affairs consulting
- Location
- Washington, DC, District of Columbia, United States of America
Lobbying activities
2 issuesBudget/Appropriations
Monitor FDA funding for inspection of counterfeit medicines and separately, oversight of compounding medicines -- both as related to the FY 2018 Agriculture Appropriations bill.
LobbyistsDIANE MAJOR · BRENDA REESE
Covered position (DIANE MAJOR): Health Policy Analyst for Senate Republican Policy Committee
Covered position (BRENDA REESE): Conference Coordinator for House Republican Conference
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)
Health Issues
Advocate for voluntary best practices related to pharmaceutical pricing. Monitor H.R. 2430, the FDA Reauthorization Act of 2017; S. 934, the Food and Drug Reauthorization Act of 2017.
LobbyistsDIANE MAJOR · BRENDA REESE
Covered position (DIANE MAJOR): Health Analyst for the Senate Republican Policy Committee
Covered position (BRENDA REESE): Conference Coordinator for the House Republican Conference
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)